2015 Antineoplastics

Identify the drug, occasionally still used in the treatment of chronic myeloid leukemia (CML), that is a direct inhibitor of ribonucleotide reductase, and which synchronizes cells in a radiation-sensitive phase of the cell cycle. Answer
            A.        Busulfan
            B.        Hydroxyurea
            C.        Imatinib
            D.        Interferon α
            E.        6-Mercaptopurine

• Outline of Sessions
• References
  • Other Lectures
• Session Objectives
  • Previous courses
  • I: General concepts
  • II. Antimetabolites
  • III. Disrupt DNA
  • IV. Antimitotics and Immune system modifiers
  • V. Protein function inhibitors
  • VI. Angiogenesis inhibitors/Differentiating agents/Treatment strategies
  • VII. Antihormone therapy
• Critical Facts
  • I. General concepts
  • II. Antimetabolites
  • III. Disrupt DNA
  • IV. Antimitotics and Immune system modifiers
  • V. Protein function inhibitors
  • VI. Angiogenesis inhibitors/Differentiating agents/Treatment strategies
  • VII. Antihormone therapy
• Resources
  • Pharm Cards
    • Instructions
    • Antineoplastics II
    • Antineoplastics III
    • Antineoplastics IV
    • AntineoplasticsV
    • AntineoplasticsVI
  • iPad/Web game
  • Tables & Summaries
  • Example test questions
    • Hematopoiesis
    • Endocrine